Zumutor Biologics Inc.
1 clinical trials · Sponsor
◉ Watch Zumutor Biologics Inc.
| Record | Firm | Date |
|---|---|---|
| This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors (NCT06451497) | Zumutor Biologics Inc. | 2024-05-22 |
Track Zumutor Biologics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.